Search hospitals > New Jersey > Lakewood
Monmouth Medical Center - Southern Campus
Claim this profileLakewood, New Jersey 08701
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Colon Cancer
Conducts research for Colorectal Cancer
46 reported clinical trials
15 medical researchers
Summary
Monmouth Medical Center - Southern Campus is a medical facility located in Lakewood, New Jersey. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Colon Cancer, Colorectal Cancer and other specialties. Monmouth Medical Center - Southern Campus is involved with conducting 46 clinical trials across 80 conditions. There are 15 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
PR positive
2Lung Cancer
Stage II
Stage I
Stage III
Top PIs
Howard S. HochsterRutgers Cancer Institute of New Jersey6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
37 drugs studied
Eugenia Girda, MDRutgers Cancer Institute of New Jersey5 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
16 reported clinical trials
31 drugs studied
Missak Haigentz, MDRutgers Cancer Institute of New Jersey4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
23 drugs studied
Mridula George, MDRutgers Cancer Institute of New Jersey2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
38 drugs studied
Clinical Trials running at Monmouth Medical Center - Southern Campus
Lung Cancer
Breast Cancer
Colon Cancer
Ovarian Cancer
Bladder Cancer
Breast cancer
Endometrial Cancer
Uterine Cancer
Pancreatic Cancer
Kidney Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Monmouth Medical Center - Southern Campus?
Monmouth Medical Center - Southern Campus is a medical facility located in Lakewood, New Jersey. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Colon Cancer, Colorectal Cancer and other specialties. Monmouth Medical Center - Southern Campus is involved with conducting 46 clinical trials across 80 conditions. There are 15 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.